Category
Xanomeline
Xanomeline
CAS Number
131986-45-3
Molecular Formula
C₁₄H₂₃N₃OS
Molecular Weight
281.42 g/mol
Synonym

Pyridine, 3-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methyl; 3-(hexyloxy)-4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazole; 3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methylpyridine;

Keywords
High-Quality Pharmaceutical Reference Standards
Intermediates
Pharmaceutical Standards
Fine Chemicals
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Xanomeline Standard (CAS No. 131986-45-3), with a Molecular Formula of C₁₄H₂₃N₃OS and Molecular Weight of 281.42 g/mol, is a pharmaceutical API analytical reference standard used in drug development, API identification, purity analysis, impurity profiling, related substances testing, HPLC method validation, and pharmaceutical quality control. Xanomeline is a muscarinic acetylcholine receptor agonist associated with research and treatment applications in neurological and psychiatric disorders, including schizophrenia. Manasa Life Sciences, a pharmaceutical reference standards manufacturer and supplier in India, offers Xanomeline API Reference Standard for pharmaceutical companies, API manufacturers, CROs, CDMOs, and analytical laboratories. Our Xanomeline analytical standards, HPLC reference materials, and pharmaceutical API standards support LC-MS/MS analysis, stability studies, pharmaceutical research, and quality control testing, with COA, SDS, and analytical characterization documentation available upon request, subject to availability.